广康生化
(300804)
| 流通市值：9.50亿 | | | 总市值：25.57亿 |
| 流通股本：2750.00万 | | | 总股本：7400.00万 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 509,385,229.18 | 382,211,123.05 | 160,416,302.71 | 754,799,505.24 |
| 营业总成本 | 529,376,132.43 | 378,926,709.86 | 162,627,495.93 | 713,052,217.39 |
| 其他经营收益 | | | | |
| 营业利润 | -17,083,320.15 | 2,815,793.65 | -1,047,851.03 | 47,223,830.14 |
| 利润总额 | -19,082,856.85 | 1,110,374.62 | -1,710,914.64 | 42,586,059.79 |
| 净利润 | -11,398,624.78 | 4,209,974.5 | -382,759.37 | 40,417,901.23 |
| 每股收益 | | | | |
| 其他综合收益 | -1,761.3 | -1,017.57 | - | - |
| 综合收益总额 | -11,400,386.08 | 4,208,956.93 | -382,759.37 | 40,417,901.23 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,141,364,518.26 | 963,531,823.32 | 951,226,780.94 | 1,088,941,347.15 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,286,028,986.6 | 1,255,260,301.59 | 1,200,417,206.75 | 1,128,346,502.48 |
| 资产总计 | 2,427,393,504.86 | 2,218,792,124.91 | 2,151,643,987.69 | 2,217,287,849.63 |
| 流动负债: | | | | |
| 流动负债合计 | 634,512,730.85 | 580,941,823.9 | 506,672,994.46 | 636,987,414.06 |
| 非流动负债: | | | | |
| 非流动负债合计 | 446,035,398.08 | 275,824,948.81 | 277,097,322.6 | 212,200,432.05 |
| 负债合计 | 1,080,548,128.93 | 856,766,772.71 | 783,770,317.06 | 849,187,846.11 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,344,918,392.84 | 1,359,903,241.75 | 1,366,912,093.04 | 1,367,331,125.55 |
| 股东权益合计 | 1,346,845,375.93 | 1,362,025,352.2 | 1,367,873,670.63 | 1,368,100,003.52 |
| 负债和股东权益合计 | 2,427,393,504.86 | 2,218,792,124.91 | 2,151,643,987.69 | 2,217,287,849.63 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 361,633,082.73 | 240,819,531.59 | 102,433,170.49 | 591,247,385.52 |
| 经营活动现金流出小计 | 400,735,739.23 | 314,269,550.05 | 160,419,032.07 | 510,328,057.01 |
| 经营活动产生的现金流量净额 | -39,102,656.5 | -73,450,018.46 | -57,985,861.58 | 80,919,328.51 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 519,718,511.15 | 371,537,091.19 | 150,511,717.77 | 2,207,858,700.64 |
| 投资活动现金流出小计 | 499,817,146.47 | 242,653,125.13 | 165,194,415.07 | 2,353,548,308.38 |
| 投资活动产生的现金流量净额 | 19,901,364.68 | 128,883,966.06 | -14,682,697.3 | -145,689,607.74 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 397,867,877.91 | 189,528,115.71 | 124,480,411.5 | 381,175,721.74 |
| 筹资活动现金流出小计 | 235,876,894.27 | 134,306,380.68 | 101,255,790.44 | 265,973,707.35 |
| 筹资活动产生的现金流量净额 | 161,990,983.64 | 55,221,735.03 | 23,224,621.06 | 115,202,014.39 |
| 汇率变动对现金及现金等价物的影响 | -2,739,889.2 | -1,606,646.75 | -916,708.9 | 1,312,615.26 |
| 现金及现金等价物净增加额 | 140,049,802.62 | 109,049,035.88 | -50,360,646.72 | 51,744,350.42 |
| 期末现金及现金等价物余额 | 313,509,820.85 | 282,509,054.11 | 123,099,371.51 | 173,460,018.23 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 109,049,035.88 | - | 51,744,350.42 |